However, early increase in tumor ADC values has been reported in subcutaneous ovarian cancer xenografts 3 days post-treatment with a PI3K/mTOR-inhibitor [37], a pathway of therapeutic interest also in EC [38]. The gene discussed is MTOR; the disease is neoplasm.